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 27 
Highlights (for review) 28 
 Nurse-led, PROMs-driven consultations to identify and address the supportive care needs of 29 
patients with CRC who transition from active chemotherapy to the initial follow-up period 30 
appear to be feasible and acceptable to both patients and CNS 31 
 Patients appreciated the opportunity for dedicated time with the CNS as it allowed them to 32 
raise concerns and get sensitive and personalised help and advice. 33 
 CNS perceived engagement in the collection and use of patient-reported data as an 34 
enlightening and educative activity, enabling them to see beyond just side-effects, assess over 35 
time, and investigate issues deeper 36 
 This type of intervention could be associated with (a) a sizeable reduction in the total 37 
number of reported unmet needs, and (b) a small decrease in the magnitude of expressed 38 
physical/daily living and psychosocial needs at the initial post-chemotherapy period. 39 
Abstract 40 
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Purpose: Logistical issues pertinent to the use of patient-reported outcome measures (PROMs) by 1 
colorectal cancer nurse specialists (CNS) to identify the needs of people with colorectal cancer (CRC) 2 
in acute care remain unknown. We explored the feasibility and acceptability of PROMs-driven, CNS-3 
led consultations to enhance delivery of supportive care to people with CRC completing adjuvant 4 
chemotherapy. 5 
Methods: A systematic literature review and focus groups with patients and CNS (Phase 1) were 6 
followed by a repeated-measures, exploratory study (Phase 2), whereby pre-consultation PROM data 7 
were collected during three consecutive, monthly consultations, and used by the CNS to enable 8 
delivery of personalised supportive care. 9 
Results: Based on Phase 1 data, the Supportive Care Needs Survey was selected for use in Phase 2. 10 
Fourteen patients were recruited (recruitment rate: 56%); thirteen (93%) completed all study 11 
assessments. Forty in-clinic patient-clinician consultations took place. At baseline, 219 unmet needs 12 
were reported in total, with a notable 21% (T2) and 32% (T3) over-time reduction. Physical/daily living 13 
and psychological domain scores declined from T1 to T3, yet not statistically significantly. In exit 14 
interviews, patients described how using the PROM helped them shortlist and prioritise their needs. 15 
CNS stressed how the PROM helped them tease out more issues with patients than they would 16 
normally.  17 
Conclusions: Nurse-led, PROMs-driven needs assessments with patients with CRC appear to be 18 
feasible and acceptable in clinical practice, possibly associated with a sizeable reduction in the frequency 19 
of unmet needs, and smaller decreases in physical/daily living and psychosocial needs in the immediate 20 
post-chemotherapy period. 21 
 22 
Keywords: Patient-reported outcome measures; unmet needs; supportive care; colorectal cancer; 23 
cancer nurse specialist; feasibility; acceptability; nurse led 24 
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Background 1 
Colorectal cancer (CRC) is the third most common cancer worldwide and second most common 2 
cancer in Europe, accounting for 9.7% and 13.0% of all cancer cases, respectively (Ferlay et al., 2013). 3 
As a result of advances in both diagnostic tests and treatments for CRC, mortality has declined over 4 
the past decades (Ait Ouakrim et al., 2015), with nearly 60% of patients now surviving to five years 5 
after diagnosis (The Scottish Public Health Observatory, 2015). This means that an increasing number 6 
of people may now live beyond CRC, but still experience the impact of illness and treatment on several 7 
aspects of their lives (Alacacioglu et al., 2010; Arndt et al., 2004; Wu and Snyder, 2011). The need to 8 
provide on-going and comprehensive supportive care to these individuals is therefore prominent 9 
(Jorgensen et al., 2012). 10 
Research has shown that people with CRC may have multiple unmet supportive care needs (Harrison 11 
et al., 2011a; Ho et al., 2016) that may well interfere with quality of life (Santin et al., 2015). Long-term 12 
recovery may be more prolonged specifically for patients receiving adjuvant chemotherapy and/or 13 
radiotherapy, due to persistent physical symptoms and an altered body image, often associated with 14 
daily living challenges, anxiety and/or depression, and complicated psychosocial adjustment (Ho et al., 15 
2016; Russell et al., 2015). 16 
The development of new clinical supportive care services for people with CRC should identify ways 17 
WR IHDVLEO\ DVVHVV DQG HIIHFWLYHO\ DGGUHVV SDWLHQWV· QHHGV 2QH VXFK VHUYLFH LV WKH XVH RI SDWLHQW-18 
reported outcome measures (PROMs) to identify the supportive care needs of people with CRC 19 
WKURXJKRXW WKH LOOQHVV WUDMHFWRU\ 5HO\LQJ RQ SDWLHQWV· RZQ UHSRUWV RI WKHLU KHDOWK VWDWXV QHHGV20 
priorities and expectations means that care can be personalised. This allows the identification of bio-21 
psychosocial issues that may otherwise be overlooked in standard clinical consultations, and facilitates 22 
timely management of symptoms, improved communication between patients and health professionals, 23 
increased shared decision-making, and greater patient satisfaction with care (Donaldson, 2004; 24 
Kotronoulas et al., 2014; Valderas and Alonso, 2008). Relevant literature indicates that nurses are the 25 
most appropriate health professionals to assess PROMs as they are more receptive to, and give greater 26 
weight to such information (Greenhalgh et al., 2005). There is also evidence to suggest that the use of 27 
3520V FDQ EH HQKDQFHG E\ WDNLQJ SDWLHQWV· DQG FOLQLFLDQV· SUHIHUHQFHV LQWR FRQVLGHUDWLRQ ZKHQ28 
selecting such tools as this ensures that FOLQLFLDQV·priorities for care are consistent with those of 29 
patients (Carr et al., 2003; Ruland, 1998; Ruland et al., 1997).  30 
It is therefore reasonable to hypothesise that PROMs can be used to transform the supportive care 31 
offered to people with CRC. However, additional research is needed to explore how the use of 32 
PROMs can be implemented in everyday practice to enable nurses to assess and address the supportive 33 
care needs of people with CRC, and how this approach can impact on patient outcomes and the 34 
clinical practice. Thus, we aimed to explore the feasibility and acceptability of the use of supportive 35 
care needs PROMs by colorectal cancer nurse specialists (CNS) in the delivery of supportive care to 36 
people with CRC receiving adjuvant chemotherapy. 37 
 38 
Methods 39 
After obtaining Research Ethics approval (14/WS/0070), we conducted a two-phase, mixed-methods 40 
exploratory study within one NHS board (3 hospitals) in Scotland. In Phase 1, we aimed to identify 41 
what outcomes are important to patients with CRC and colorectal CNS involved in their care. This 42 
information determined selection of a PROM for use in Phase 2. Phase 2 addressed the following 43 
objectives: 44 
x Explore parameters of feasibility and acceptability pertinent to use of a PROM by patients with 45 
CRC and their CNS in the delivery of supportive care. 46 
x Describe the supportive care needs of patients with CRC, receiving adjuvant chemotherapy. 47 
x Determine whether the PROM is sensitive to change over time. 48 
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 1 
Phase 1 2 
In Phase 1, we combined evidence from a systematic literature review with data from subsequent 3 
focus groups interviews with patients with CRC and colorectal CNS. 4 
Systematic literature review 5 
We conducted our review according to the Preferred Reporting Items for Systematic Reviews and 6 
Meta-Analyses (PRISMA) guidelines (Moher et al., 2009). The review aimed to appraise the empirical 7 
evidence on the supportive care needs of people with CRC. Full methodological details of this review 8 
have been published separately (Kotronoulas et al., 2017). The review also aided in the identification 9 
of supportive care needs PROMs that were used as part of the included studies. The identified PROMs 10 
were added to the pool of supportive care needs PROMs already known to us from previous reviews 11 
(Carlson et al., 2012; Maguire et al., 2013; Richardson et al., 2007). All PROMs were considered for 12 
use in Phase 2.  13 
 14 
Stakeholder interviews 15 
Two focus group interviews ² one with patients and one with nurses ² each consisting of no more 16 
than ten participants were conducted. The interviews aimed to provide information on supportive 17 
care outcomes considered important by people with CRC and by CNS involved in their care. All 18 
colorectal CNS, registered within the participating NHS board, were invited to participate and identify 19 
eligible patients. Patients with CRC were identified through outpatient lists at the participating 20 
hospitals. Eligible patients were those (a) receiving adjuvant chemotherapy for early-stage CRC; (b) 21 
deemed as physically and psychologically fit for participation; (c) able to read and write English; (d) 22 
able to provide written informed consent; (e) aged 18 years or over; and (f) able to provide consent 23 
for members of the research team to access their case notes. 24 
The two focus groups were conducted separately, on different dates, and in a meeting room at one of 25 
the participating hospitals. All consenting patients and CNS provided written informed consent. 26 
Interview guides were used to facilitate discussion. Focus groups were planned to last for no more 27 
than one hour to minimise participant burden. At the end of each focus group, we involved participants 28 
in a 10-minute exercise. Copies of the previously author-selected PROMs were distributed to each 29 
group. We asked participants to review the PROMs and select, in order of descending preference, the 30 
WKUHH ¶PRVWDSSURSULDWH· IRUXVHZLWKSHRSOHZLWK&5&3DUWLFLSDQWVZHUHDVNHGWR IRFXVRQVXFK31 
aspects as overall presentation, length, wording, and comprehensiveness as indicators of PROM 32 
appropriateness. 33 
 34 
 35 
Phase 2 36 
Phase 2 entailed a prospective, repeated-measures study that aimed to involve up to 30 patients with 37 
CRC as per current available guidance for early feasibility testing (Lancaster et al., 2004). Participation 38 
of the CNS was re-confirmed for Phase 2. Patient eligibility criteria were identical to those used in 39 
Phase 1. All consenting patients provided written informed consent. None of the patients who were 40 
involved in Phase 1 participated in Phase 2.  41 
Procedures 42 
Patients participated in Phase 2 over three, equally-spaced (monthly) time-points: penultimate 43 
chemotherapy cycle (T1); last chemotherapy cycle (T2); and approximately one month after the last 44 
chemotherapy cycle (T3). Timing of the intervention was selected in consultation with CNS 45 
participants. Patient transition from active treatment to the initial follow-up period was perceived as 46 
an important period for the provision of effective supportive care. This timeline was also thought to 47 
allow sufficient time for feasibility testing, whilst minimising the attrition rate. 48 
5 
 
At each time-point, participating patients were booked on an appointment with their CNS. Whilst in 1 
the clinic and prior to their consultation, patients were asked to complete the selected needs 2 
assessment PROM in a quiet room. Subsequently, the CNS met with the patient and used the 3 
LQIRUPDWLRQ FROOHFWHG YLD WKH 3520 WR LGHQWLI\ WKH SDWLHQW·V VXSSRUWLYH FDUH QHHGV direct 4 
consultations, and intervene accordingly. The CNS documented any needs they identified and any 5 
resulting interventions in author-developed case-report forms. Finally, up to ten patients and all CNS 6 
were planned to participate in one-to-one, end-of-study, semi-structured interviews to explore their 7 
perceptions on the intervention in greater depth. 8 
Data analysis 9 
PROM data were analysed using SPSS (IBM SPSS Inc., Chicago, IL, USA) descriptive statistics 10 
functionality and graphs. Frequency counts for each response were generated to quantify missing data 11 
and describe response patterns for PROM items. Missing data were replaced using multiple imputation. 12 
To assess sensitivity to change, the mean, standard deviation and median of PROM subscale scores, 13 
and effect sizes of changes thereof were calculated. Effect sizes were calculated as the difference 14 
between a mid-point and baseline score (T1 to T2; T1 to T3) divided by the standard deviation of the 15 
baseline scores. Negative values reflected improvements in the number of standard deviations of the 16 
EDVHOLQHVFRUHV(IIHFWVL]HVZHUHFRQVLGHUHGODUJH²0.79 moderate, 0.20²0.49 small, and 17 
0.00²0.19 very small (Kazis et al., 1989). Q-Q plots, histograms and Shapiro-:LON·VWHVWV were used 18 
to check the assumption of normality in PROM subscale scores. Due to deviations from normality, 19 
Friedman ANOVA was used to test for statistical significance of changes in PROM subscale scores 20 
over 3 assessment points (with post-hoc comparisons). The level of significance was set at 0.05. 21 
Focus group and end-of-study interviews were audio-recorded and transcribed verbatim. NVivo 9 22 
(QSR International) was used to aid the organisation of data. Thematic content analysis (Braun and 23 
Clarke, 2006) was used to help answering questions about the salient issues for a particular group of 24 
respondents or for identifying typical responses. Whilst analysis of the data was thematic, it also 25 
focussed on whether and how participants agreed or disagreed about each topic on our topic guides.  26 
 27 
Results 28 
Phase 1 29 
Systematic literature review 30 
After initial screening of 3709 references, 54 unique studies were retained and included in a narrative 31 
synthesis of evidence (Kotronoulas et al., 2017). Emotional support and reassurance when trying to 32 
deal with fear of the cancer returning or spreading featured as the most prominent need regardless of 33 
clinical stage or phase of treatment. A top-10 of most prominent needs also included more information 34 
about diet/nutrition and about long-term self-management of symptoms and complications at home; 35 
tackling issues relating to the quality and mode of delivery of health-related information; help with 36 
controlling fatigue; and on-going contact with a trustworthy health professional (Kotronoulas et al., 37 
2017). 38 
Based on the above findings and drawing on our database of needs assessment PROMs, we concluded 39 
that the following six PROMs would be discussed in subsequent focus groups: Supportive Care Needs 40 
Survey ² Short Form 34 (SCNS-SF34) (Boyes et al., 2009); Problems Checklist (Cull et al., 1995); 41 
Cancer Needs Questionnaire ² Short Form (Cossich et al., 2004); Psychosocial Needs Inventory 42 
(McIllmurray et al., 2001); Cancer Survivors Unmet Needs (Hodgkinson et al., 2007); Functional 43 
Assessment of Cancer Therapy-Colorectal concerns subscale (FACT-C) (Ward et al., 1999). These 44 
PROMs were selected IRUWKHLUEUHYLW\DQGFRPSUHKHQVLYHQHVVLQDVVHVVLQJSDWLHQWV·VXSSRUWLYHFDUH45 
needs. 46 
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Stakeholder focus group interviews 1 
The focus groups were conducted in October 2014. Eleven patients with CRC were invited to take 2 
part, but three refused due to lack of time. Thus, the first focus group involved eight patients with 3 
&5&3DUWLFLSDQWV·DFFRXQWVPDLQO\UHYROYHGDURXQGLVVXHVRILQIRUPDWLRQVKDULQJQDYLJDWLRQWKURXJK4 
the health service, and patient-clinician communication. The group described their need to receive 5 
comprehensive information about the illness and its treatment (surgery, stoma, recovery, symptoms 6 
and management thereof), and how important it is for this information to be communicated in a 7 
sensitive way. Participants would welcome a more swift reply to their needs, too. Those who had a 8 
VWRPDDOVRVSRNHDERXWWKH´shockµRIJHWWLQJRQHDQGWKHQHHGWRUHFHLYHSV\FKRORJLFDOVXSSRUW7KH9 
group talked about the supportive role of their families and friends was in helping them to keep a 10 
SRVLWLYHRXWORRN2QHSDUWLFLSDQWH[SODLQHG´$V\PSDWKHWLFHDUWKDW·VUHDOO\ZKDW,QHHGHGDWWKHWLPHµ11 
2WKHUVDGPLWWHGWU\LQJWR¶SURWHFW·WKHLUIDPLOLHVWKHUHE\DYRLGLQJFRPPXQLFDWLRQDOWKRXJKWKH\PD\12 
have needed it. When queried, participants revealed that their social needs had not been thoroughly 13 
assessed. Nonetheless, the group spoke about the need to return to normal, to find new meaning in 14 
life, and to resume work or get help if returning to work was not an option anymore. 15 
The second focus group involved all seven colorectal CNS registered within the participating NHS 16 
board7KH&16VSRNHRIWKHHYHUFKDQJLQJQDWXUHRIRQH·VQHHGVIURPFDQFHUGLDJQRVLVWRWUHDWPHQW17 
and then to follow-up, but stressed the need for on-going support for patients who are in the post-18 
treatment phase. The group agreed that people with CRC need to have a clinician responsible for 19 
their care, one that they know they can contact if any issues arise. The group did see themselves as 20 
this front-line clinician. One CNS spoke about variability in the information needs of this patient 21 
population, but acknowledged that such information must be clear, appropriate, accurate and 22 
consistent. The group described how patients strive to know more about their illness and about the 23 
care plan for them: they want to know what happens next and how they can be supported (e.g. with 24 
GLHWDU\FKDQJHVZLWKFRSLQJZLWKDVWRPDRUZLWKVWRPDFDUH(FKRLQJSDWLHQWV·YLHZVQXUVHVDVVHUWHG25 
that patients need help with psychological and emotional issues, family support, and practical issues, 26 
including getting help with finances, work or child support. The group agreed that use of a needs 27 
assessment PROM would allow them to structure their assessments and better understand what needs 28 
are priority for patients. 29 
Both groups regarded the SCNS-SF34 as the most appropriate PROM in terms of presentation and 30 
wording. However, CNS commented on the lack of comprehensiveness of the SCNS-SF34 and agreed 31 
that they would prefer using an even more comprehensive tool, such as the original 59-item SCNS 32 
(Bonevski et al., 2000; Sanson-Fisher et al., 2000). This was regarded a better option than combining 33 
the SCNS-SF34 with another PROM from the pool. After consensus was reached, a 60th item was also 34 
GHYHORSHGWRDVVHVVSDWLHQWV·FRJQLWLYHQHHGV´1RWEHLQJDEOHWRUHPHPEHUWKLQJVDQGRUQRWEHLQJ35 
DEOHWRFRQFHQWUDWHµDQGIXUWKHULQFUHDVHFRPSUHKHQVLYHQHVVRIWKH6&16 36 
The SCNS is a well-established and thoroughly validated, self-reported tool for assessing the perceived 37 
unmet needs of cancer patients (Bonevski et al., 2000; Sanson-Fisher et al., 2000). Respondents are 38 
asked to indicate their level of need for help over the last month on a 1-5 scale (1=not applicable, 39 
2=satisfied, 3=low need, 4=moderate need, 5=high need). Items are classified into five (factor-analysis-40 
derived) domains of need: (1) psychological (22 items); (2) health system and information (15 items); 41 
(3) physical and daily living (7 items); (4) patient care and support (8 items); and (5) sexuality (3 items) 42 
Four additional items are not incorporated within any domain, but are included as clinically important. 43 
In our study, internal consistency reliability was YHU\JRRG&URQEDFK·VDOSKD IRUDOPRVWDOO44 
domains and time-points (Suppl.1). 45 
 46 
Phase 2 47 
Feasibility and acceptability estimates 48 
Between January and July 2015, 25 eligible patients with CRC were invited to Phase 2. Eleven patients 49 
refused participation due to lack of time or interest, or challenging personal circumstances. Fourteen 50 
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patients provided written informed consent. A recruitment rate of 56% (14/25) and an average 1 
recruitment pace of 2 participants per month were achieved. Thirteen patients (93%) completed all 3 2 
study assessments, with one patient withdrawing soon after baseline assessment due to declining health 3 
status.  4 
Six CNS performed a total of 40 in-clinic patient assessments within a period of 9 months (i.e. the 5 
SHULRGZKHQWKHVWXG\ZDV¶RSHQ·IRUUHFUXLWPHQWDQGIROORZ-up). Five CNS had at least 6 years of 6 
experience in the care of people with CRC. Full documentation records (case-report forms) were 7 
received for each in-clinic assessment. Reflection questions were filled out for all 40 in-clinic 8 
assessments. Completeness of background data reached 98.2%. 9 
Forty questionnaire packs were returned (100%), one for each-clinic assessment. Data completeness 10 
analysis indicated that across 2420 actual data, only 6.1% were missing across 3 assessment points. 11 
SCNS completeness reached 97.1% at baseline, and dropped to 92.5% and 91.9% at T2 and T3, 12 
respectively. No skewed patterns of missing data were identified. The item with the greatest amount 13 
of missing data was the additional cognitive needs question (28.2%).  14 
Prevalence and over-WLPHFKDQJHVLQSDWLHQWV·QHHGV 15 
Patients were typically men (64.3%), aged 66 years, married or partnered (86%), retired (50%) and 16 
with high school education (86%) (Table 1). Twelve had a diagnosis of colon cancer. The majority of 17 
participants (57%) had stage III disease at the time of diagnosis. At baseline (T1), performance status 18 
was very good for 6 patients (ECOG PS 0) and good for 8 patients (ECOG PS 1).  19 
Figure 1 shows trajectories of number of unmet needs LH6&16LWHPVUHSRUWHGDVDWOHDVW¶ORZQHHG· 20 
for individual patients, confirming high variability in this sample. At T1, a median 15.5 (range 0-40) 21 
unmet needs per patient were reported, accounting for a total of 219 reported needs across the study 22 
sample. These figures slightly dropped to a median 14.5 (range 0-30) unmet needs per patient at T2 23 
(total 173; 21% reduction from T1), with a further decline at T3 (median 5.5, range 0-38; total 148; 24 
32% reduction from T1).  25 
Following two consecutive consultations, the prevalence of unmet needs dropped at or below 50% at 26 
T3, with T1-to-T3 reductions ranging from 21% to 29% (Suppl.2). At T1, fears about the cancer 27 
spreading or returning, lack of energy and not being able to do things they used to do were the most 28 
frequent concerns of this patient group, remaining prominent (top-3 needs) at T2 and T3 (Table 2). 29 
Uncertainty about the future was also prominent at baseline (64.3%), but its frequency declined steadily 30 
from T2 to T3. Concerns about the family, concerns about financial issues, and anxiety and depressed 31 
mood were also prevalent needs at baseline. From T2 to T3, a rise in ¶UHKDELOLWDWLRQ·QHHGVZDVDOVR32 
noted, whereby patients indicated their need to accommodate changes in usual routine and lifestyle, 33 
feel in control of their situation, deal with concerns about losing their independence, keep a positive 34 
outlook, and find wD\V WR EHFRPH ¶XVHIXO· DJDLQ )URP EDVHOLQH WR 7 DQ XSZDUG WUHQG LQ WKH35 
SUHYDOHQFHRISDWLHQWV·QHHGWRJHWKHOSZLWKGHSUHVVHGPRRGZDVQRWHGDULVHRIWZRSODFHVLQWKH36 
UHOHYDQWUDQNLQJ&RQYHUVHO\SDWLHQWV·QHHGWRJHWKHOSZLWKILQDQFLDOLVVXHVZDs less prevalent at T2 37 
and at T3 compared to baseline (Table 2). 38 
Patients had a greater need for support with physical/daily living and psychological issues, followed by 39 
sexuality needs. Comparably, information needs and patient care/support needs were less prominent 40 
(Table 3). Examination of over-time trajectories indicated a slight gradual decline in the mean score of 41 
physical/daily living needs and psychological needs from T1 to T3. No particular trends were found for 42 
information needs or patient care/support needs. Mean scores of the sexuality needs domain declined 43 
from T1 to T2, but increased above baseline levels at T3. 44 
Effect sizes of over-time changes were predominantly negative (i.e. showing reduction in the magnitude 45 
of needs), but overall very small (Table 4). Small effect sizes were found for the change in physical/daily 46 
living needs scores from T1 to T3 (-0.33), the change in psychological needs scores from T1 to T3 (-47 
0.29), and the change in patient care/support needs scores from T1 to T2 (-0.21). The only moderate 48 
effect size was found for the change in sexuality needs scores from T1 to T2 (-0.51). No statistically 49 
significant over-time changes were found for any of the SCNS domains of need (all p>0.05; Suppl.3). 50 
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End-of-study interviews: Patients 1 
Twelve patients initially consented to end-of-study interviews; no contact was made possible for 6 of 2 
them. Two additional patients were not interested at the time and declined participation. Four patients 3 
re-confirmed participation, but only 3 were actually interviewed. One patient never attended the 4 
interview and no further contact with them was made possible. 5 
7KUHH PDLQ WKHPHV HPHUJHG IURP WKH DQDO\VLV RI SDWLHQW LQWHUYLHZ GDWD QDPHO\ D SDWLHQWV·6 
experiences of the health service, (b) a host of needVUDLVHGGXULQJFRQVXOWDWLRQVDQGFSDWLHQWV·7 
LQYROYHPHQWLQWKHSURMHFW:LWKLQWKH¶SDWLHQW·VLQYROYHPHQWLQWKHSURMHFW·WKHPHVXEWKHPHVLQFOXGHG 8 
x Appropriate need management. Patients were very satisfied with how their needs were dealt 9 
with by the QXUVHVSHFLDOLVWV´,VDZYDOXHLQLWIRUPH«LWZDVQ·WMXVWDFDVHRIDQVZHULQJTXHVWLRQV10 
DQGKHUH·VWKHSDSHUWKDQN\RX«WKHQXUVHZRXOGWDONWRPHDERXWLWDQG\RXNQRZDVNPHKRZ,11 
felt about it and she would try to explain thingsµ>3@´And so I left there reasonably happy with the 12 
DGYLFH,ZDVJHWWLQJ«µ>3@DQGKRZWKH&16ZDVDEOHWRVXSSRUWWKHPWKURXJKDFKDOOHQJLQJ13 
SHULRG´ «DQGIRUWKHPWRWDNHWLPHRXWWRVLWDQGWDONWR\RXDQGH[SODLQZKDW·VDOOJRLQJWRKDSSHQ14 
what to worry about, what nRWWRZRUU\DERXW\RXNQRZ«WKHQXUVHVZHUHJUHDWµ>3@ 15 
x Benefits of using the PROM. Use of the PROM was viewed as bringing to the fore issues that 16 
WKHSDWLHQWPLJKWQRWKDYHUHPHPEHUHGRWKHUZLVH´VRPHWLPHV\RXH[SHULHQFHIHHOLQJV>«@DQG17 
by the time you FRPHWRVHHWKHQXUVHV\RX·YHPD\EHIRUJRWELWVDQGSLHFHVµ>3@DVZHOODVLVVXHV18 
WKDW WKH SDWLHQW PLJKW QRW KDYH UDLVHG KDG WKH\ QRW VHHQ LW ZULWWHQ GRZQ ´I think this 19 
TXHVWLRQQDLUHLVDJRRGWKLQJ>«@LWEULQJVXSWKLQJVWKDWPD\EH\RXKDGQ·WWKRXJKt of and you think 20 
RKWKDW·VULJKWHQRXJKµ>3@ 21 
x Experiences of using the PROM, attending the consultation, and being involved in research. 22 
7KH6&16ZDVHDV\WRXQGHUVWDQG´«WKHTXHVWLRQVZHUHDOOTXLWHVWUDLJKWIRUZDUGµ>3@DQG23 
complete in 10-20 minuteV ´,GLGQ·W ILQG LW WRR ORQJµ>3@ WKHGXUDWLRQRIWKHFRQVXOWDWLRQ24 
DSSURSULDWH´,ZRXOGQ·WKDYHPLQGHG LI LWZHQWRQDZHHELW ORQJHUDFWXDOO\µ>3@DQGSDWLHQWV25 
ZHUHZLOOLQJWRWDNHSDUWLQUHVHDUFK´,ZDVTXLWHZLOOLQJWRSDUWLFLSDWH«DQ\WKLQJWKDt kind of 26 
way helpsµ>3@´«TXLWHKDSS\WRJRWKURXJKLW<RX·UHORRNLQJDWILUVWDQGVD\´RKER\µEXWWKHQ27 
when you start to read, then you know what you want to sayµ>3@ 28 
x Timing of the intervention. Having the intervention towards the end of chemotherapy was 29 
seen as useful; during that time the psycho-HPRWLRQDOQHHGVEHFRPHPRUHHYLGHQW´towards 30 
WKH HQG ZKHQ \RX·UH VWDUWLQJ WR IHHO EHWWHU SK\VLFDOO\ LW·V WKH PHQWDO WKLQJ WKDW NLFNV LQµ >3@31 
However, the patients expressed the view that introduction of this intervention near the 32 
beginning of the journey would also be beneficial, when patients face the fear of the unknown: 33 
´,ZRXOGQ·WPLQGLILWKDGVWDUWHGDZHHELWHDUOLHU\RXNQRZZKHQ\RXUIHDUNLFNVLQµ>3@ 34 
End-of-study interviews: Colorectal CNS  35 
Six CNS participated in end-of-study interviews. Three main themes were identified, namely (a) using 36 
PROMs in practice, (b), challenges of the study and (c) suggestions for future work. 37 
:LWKLQWKH¶using PROMs in practice·WKHPHWKH&16HVWLPDWHGWKat on average consultations lasted 38 
30-40 minutes, noting how the intervention became easier to deliver after a few consultations and as 39 
they got more confident with the process. All CNS agreed that, in most instances, they were able to 40 
deal with the issues raised either by using their own resources or by referring to other services. The 41 
CNS expressed how helpful it was to use the tool to tease out more issues with the patients than 42 
WKH\ZRXOGQRUPDOO\´[it] initiates conversations that are deeperµ>1@´It was certainly good to have a 43 
SURPSW«>1@7KH\DOVRFRPPHQWHGRQKRZWKH\ZHUHPDGHDZDUHRIPRUHSDWLHQWQHHGV´[he 44 
ZDV@RQFKHPRWKHUDS\DQGKHFRXOGQ·WKDYHVH[XDOFRQWDFWZLWKKLVZLIH«KH·VDQROGHUJHQWOHPDQVR\RX45 
GRQ·WNLQGRIWKLQNDERXWWKHVHWKLQJV$QG,WKRXJKWZHOOWKDW·VTXLWHLQWHUHVWLQJFRVLW·VFHUWDLQO\QRWWKHNLQG46 
of thing that comes up during a kind of normal clinic consultationµ>1@´One lady actually [said] it was more 47 
KHUIDPLO\WKDWZDVWKHLVVXH«ZKLFKVKHQHYHUKDGVSRNHQ about beforeµ>1@(YHQWXDOO\WKHLQWHUYHQWLRQ48 
ZDVUHJDUGHGDVHGXFDWLYHDQGZRUWKZKLOH´I do think that [it] has been a learning experience to meµ49 
>1@´,IRXQGLW>WKHWLPHVSHQWZLWKWKHSDWLHQW@UHDOO\WKHUDSHXWLF«LWUHDOO\HQKDQFHGWKHUHODWLRQVhip [with 50 
WKHSDWLHQW@«DQGLWZDVTXLWHDQH\HRSHQHUµ>1@ 51 
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,QWHUPVRI¶challenges of the study·LVVXHVUDLVHGLQFOXGHGVRPHFRQFHUQVWKDWWKHTXHVWLRQVZHUH´too 1 
manyµRUWRRPXFKUHSHWLWLRQZDVLQYROYHGDVWKHTXHVWLRQVZHUHQRWUHOHYDQWDWDOOWLPH-SRLQWV´I 2 
WKLQNLQLWLDOO\WKHTXHVWLRQVZHUHILQHDQGLWFHUWDLQO\SLFNHGXSDORWRIWKLQJVWKDWQHHGHGWREHSLFNHGXS«3 
but I just think it was the second two legs of it that was a wee bit repetitiveµ>1@RUWKDWWKHFRQVXOWDWLRQV4 
would take too long EHFDXVHTXHVWLRQVZRXOGWULJJHUDPRUHJHQHUDOWKDQIRFXVVHGGLVFXVVLRQ´it was 5 
YHU\GLIILFXOWWRJHWWKHPWRIRFXVRQWKHODVWSHULRGRIWLPH«6RWKHUH·VDORWRIFKDWSUREDEO\LQEHWZHHQLW6 
WKDWZDVQ·WUHOHYDQWWRWKHDFWXDOVWXG\µ>1@$GGLWLRQDOFKDllenges related to more general research 7 
DFWLYLWLHV)RU LQVWDQFHRQH&16FRPPHQWHGRQWKH WLPH LQWHUYDOEHWZHHQDVVHVVPHQWV ´the time 8 
between each visit could have been a wee bit longerµ>1@0RUHRYHUWKHQXPEHUVUHFUXLWHGZHUHVHHQ9 
as disappointing: ´we all thought oh 10 patients ² WKDW·VDGRRGOHZH·OOKDYHQRERWKHUZLWKWKDWDWDOO«10 
DQGWKDWMXVWZDVQ·WWKHFDVHµ>1@ 11 
¶Suggestions for future work·LQFOXGHGEURDGHQLQJWKHLQWHUYHQWLRQRXW´«RSHQLWXSDZHHELWEHFDXVH,12 
felt at our clinics we have a lot of metastatic patients, and I felt we were pretty restricted with just the adjuvantµ13 
>1@,QDGGLWLRQ&16IHOWWKHQHHGWRIROORZSHRSOHIRUDORQJHUWLPHSHULRG´I think on reflection I 14 
would probably have wanted to start it when they started their treatmentµ>1@ ´,GRQ·W NQRZPD\EH15 
PRQWKVRUPRQWKVRUVRPHWKLQJOLNHWKDW«DIWHUWKHLUWUHDWPHQW·VILQLVKHGµ>1@´then maybe at a follow-16 
up appointment you know 6 months after thatµ>1@2QH&16IHOWWKDWNHHSLQJWKHFRQVXOWDWLRQIDFH-17 
to-fDFHZDVLPSRUWDQWEHFDXVHRIWKHSHUVRQDOQDWXUHRIWKHLVVXHVGLVFXVVHGDQGDOVREHFDXVH´WKHUH·V18 
non-verbal cues that you pick up on as wellµ>1@ 19 
 20 
Discussion 21 
This study has shown that nurse-led, PROMs-driven consultations to identify and address the 22 
supportive care needs of patients with CRC who transition from active chemotherapy to the initial 23 
follow-up period appear to be feasible and acceptable to both patients and CNS. Our systematic 24 
review identified more than 50 studies that demonstrated the variability and extent of unmet needs of 25 
people with CRC across different phases of the illness trajectory (Kotronoulas et al., 2017). Young et 26 
al. (Harrison et al., 2011b; Young et al., 2010) SRLQWRXWWKDWLQFRPSDULVRQ´WKHUHLVUHODWLYHO\OLWWOH27 
LQWHUYHQWLRQDO UHVHDUFK WR GHYHORS DQG HYDOXDWH VWUDWHJLHV WR DGGUHVV WKHVH QHHGVµ 3UHYLRXV28 
interventions have targeted patients with CRC during either the immediate post-operative period 29 
(Young et al., 2010) or survivorship (Macvean et al., 2007; Siegel et al., 1992). Somewhat differently, 30 
our study aimed to address the needs of those transitioning from active chemotherapy to post-31 
treatment in line with clinical priorities identified by our study participants. This is an equally important 32 
phase, where new or rekindled needs for information and emotional support may arise for patients 33 
preparing to start another treatment modality; similarly, psychosocial, rehabilitation and daily living 34 
needs may become more prominent for those who enter survivorship. The intervention provides a 35 
mechanism by which gaps in clinical care at this transitional point could be identified and addressed 36 
promptly. 37 
Although the target goal of 30 participants in Phase 2 was not met, we were nevertheless able to 38 
confirm availability and recruitment estimates for future use. Fluctuations in the numbers of patients 39 
diagnosed/treated are a known factor to influence availability of research participants. We purposely 40 
opted for inclusive eligibility criteria: this was translated into 4 eligible patients per month about to 41 
enter the penultimate chemotherapy cycle. Broadening the scope of the intervention to involve newly 42 
diagnosed patients and/or CRC survivors, could reliably increase patient availability. A modest 43 
recruitment rate of 56% may have been the result of a challenging treatment period, illness 44 
progression, competing research projects and/or the requirement for in-person attendance that 45 
possibly deterred some patients from considering participation. The few studies that have evaluated 46 
interventions to reduce unmet supportive care needs generally achieved higher recruitment rates 47 
(>80%) (Harrison et al., 2011a, 2011b; Young et al., 2010), but the timing (post-operatively) and design 48 
(telephone consultations) employed were different and might have been more appealing to 49 
forthcoming participants. Conversely, retention rate was near perfect (93%), which is comparably 50 
higher than rates reported in similar intervention studies. Potential reasons may include the relatively 51 
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short follow-up and relevant timing of the intervention. In the study by (Young et al., 2010), it was 1 
research nurses who delivered a supportive care needs intervention for post-operative patients with 2 
CRC as an adjunct to current services. In contrast, we relied on actual members of the clinical team 3 
to incorporate the intervention as part of their clinical practice. This approach renders our findings 4 
on retention rates and in-clinic assessment performance even more compelling and relevant to clinical 5 
practice, thus further supporting feasibility and acceptability of the intervention. In Phase 2, six highly 6 
experienced CNS were involved, thus increasing the odds for seamless delivery of the intervention. It 7 
is acknowledged that this may not reflect the situation in other clinical settings, where staff shortages 8 
may hinder intervention testing and implementation. However, we believe that, by applying the 9 
intervention in real-life clinical circumstances and by keeping research support to a minimum, we were 10 
able to establish a realistic view of the facilitators and barriers of implementing this intervention. 11 
Intervention acceptability was also high. Completeness of PROM and case report form data exceeded 12 
90% both within and across time-points. It was interesting to see that the item with the greatest 13 
amount of missing data was the one about cognitive deficits. Being the last question printed on the 14 
back of the SCNS sheet, we can assume that some patients simply missed it. Limited relevance is a 15 
less likely possibility based on our review and empirical findings (Kotronoulas et al., 2017). In end-of-16 
study interviews, patients and health professionals expressed very positive opinions about the 17 
intervention. Patients appreciated the opportunity for dedicated time with the CNS as it allowed them 18 
to raise concerns and get sensitive and personalised help and advice. Patients endorsed the 19 
standardised use of an easy-to-understand needs assessment PROM as a means to help them shortlist, 20 
report and prioritise their needs, and as a reminder that no need is too unimportant to be discussed 21 
with the CNS. Similar to CNS, patients agreed that timing of the intervention was appropriate and 22 
relevant, which further underpins the high retention rates documented in the study. Moreover, 23 
participating CNS perceived engagement in the collection and use of patient-reported data as an 24 
enlightening and educative activity, enabling them to see beyond just side-effects, assess over time, and 25 
investigate issues deeper. As with the majority of PROM-related research (Kotronoulas et al., 2014), 26 
QRVSHFLILFFOLQLFDODOJRULWKPVJXLGHOLQHVRUWUDLQLQJZHUHJLYHQWR&16WRKHOSWKHPGHDOZLWKSDWLHQWV·27 
needs. Owing to their clinical expertise, CNS were well prepared to DGGUHVV SDWLHQWV· QHHGV28 
Consecutive needs assessments were however perceived as repetitive. When used in practice, the 29 
SCNS proved to be rather lengthy and incorporated items that CNS viewed as duplicates in repeated 30 
measures. We cannot rule out the possibility that some of the CNS might have seen this as a downside 31 
of their involvement, which might deter them from use of PROM data outside research. Moreover, 32 
some nurses did feel unsure about how best to address concerns that were more complex and touch 33 
upon deeper issues than those physical or practical. It is true that supplying CNS with additional 34 
information on available resources as well as training in focussed problem-solving techniques could 35 
increase intervention applicability and acceptability, also allowing for smoother involvement of the 36 
more junior members of staff. 37 
Our preliminary analyses also indicated that this type of intervention could be associated with (a) a 38 
sizeable reduction in the total number of reported unmet needs, and (b) a small decrease in the 39 
magnitude of expressed physical/daily living and psychosocial needs at the initial post-chemotherapy 40 
period. The apparent reduction in the total number of expressed unmet needs over time could be the 41 
result of either patients gradually recovering from chemotherapy or actual intervention effects taking 42 
place, or both. It is reasonable to hypothesise that, to a certain extent, some patient needs were likely 43 
to increase due to patients facing new challenges in the initial post-chemotherapy period. Thus, simply 44 
relying on the natural course of patient recovery cannot provide a complete explanation for our 45 
observations. It seems reasonable to presume that intervention effects have also taken place, in that 46 
those new and/or re-emerging needs were identified and addressed during the first and second 47 
FRQVXOWDWLRQLQSUHSDUDWLRQIRUSDWLHQWV·WUDQVLWLRQWRWKHSRVW-chemotherapy period. From T1 to T3, 48 
at least 3 or 4 patients fewer (around 20%-30%) reported unmet needs, including fear of a cancer 49 
metastasis, uncertainty about the future, financial concerns or concerns about their family coping with 50 
the situation. One explanation could be that the intervention did work, in that CNS offered effective 51 
help and support with such needs. Alternatively, at T3, some of the previously identified needs may 52 
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have not been relevant anymore. These preliminary estimates of intervention effectiveness will need 1 
confirmation in a subsequent controlled trial. 2 
As with previous longitudinal research (Lam et al., 2016), certain patient needs remained prominent 3 
(and to an extent unmet) throughout our study. Dealing with fear of recurrence, lack of energy, and 4 
the inability/difficulty to return to normal were ranked as top unmet needs regardless of time-point. 5 
It may be that, due to the life-threatening nature of the illness and intensity of treatment, such needs 6 
or concerns may be persistent and pervasive, and for that reason less amenable to interventions of 7 
this type and/or duration. Bearing in mind that no specific training or additional resources were offered 8 
to CNS, incorporating a referral algorithm could enable greater/better use of available resources and 9 
more effective management of such patient needs.  10 
Equally, it is interesting to see how specific needs became more relevant/prominent at post-11 
FKHPRWKHUDS\ 7KHVH LQFOXGHG FKDQJHV WR RQH·V URXWLQH OLIHstyle and sexual relationships, fighting 12 
GHSUHVVLRQJHWWLQJFRQWURORIRQH·VVLWXDWLRQPDLQWDLQLQJ LQGHSHQGHQFHRU IHHOLQJXVHIXOWRRWKHUV13 
DQGWKHVRFLHW\6XFKLVVXHVUHYHDOSDWLHQWV·QHHGIRUUHKDELOLWDWLRQDQGDGMXVWPHQW6XFKVSLNHVLQQHHG14 
may counteract the intervention tested here. However, it is also possible that the intervention actually 15 
facilitated a safe environment for patients to reflect on these needs and get support in a way that 16 
superseded current clinical practice. In other words, one cannot rule out the possibility that the 17 
observed prevalence rates related to these needs were suppressed because of intervention effects and 18 
in comparison to usual care; this can only be regarded as a positive outcome that nonetheless warrants 19 
confirmation in a future trial. 20 
Finally, diverse over-time trajectories in SCNS domain scores were noted. Despite the absence of 21 
statistically significant changes, the magnitude of patient needs in the physical/daily living and 22 
psychological domains did show a gradual decline over time. Effect sizes were rather small, but 23 
suggestive of satisfactory responsiveness to change. Information needs and needs for patient care and 24 
support emerged as the least prominent in this patient group compared to scores on all other domains. 25 
This can be explained by the timing of the intervention, whereby patients approaching the end of at 26 
least two months of post-operative chemotherapy felt that they had the information necessary to feel 27 
in control and confident to make decisions. Due perhaps to this fact, scores on these domains 28 
remained stable over time and systematically lower than the scores of other domains. Interestingly, 29 
the greatest fluctuation in over-time scores was observed for sexuality needs, with moderate positive 30 
and negative effect sizes suggesting high sensitivity to change. We noted a curvilinear pattern of change, 31 
whereby sexuality need scores dropped clinically significantly from the first to the second consultation 32 
session, but then returned close to baseline levels after the end of chemotherapy. This pattern may 33 
suggest a radical change in the nature and intensity of sexuality/intimacy needs from active treatment 34 
to post-WUHDWPHQWWKDWUHQGHUHGQXUVHV·DGYLFHDQGVXSSRUWWRSDWLHQWVWKRXJKVXFFHVVIXOIURP7WR35 
T2, insufficient to address new sexuality/intimacy challenges that may have been complicated by 36 
additional social adjustment and rehabilitation issues. In addition to paying attention to sexuality needs 37 
expressed close to the end of chemotherapy, a pro-active approach to management of future 38 
¶UHKDELOLWDWLRQ· VH[XDOLW\LQWLPDF\ QHHGV IRU WKLV SDWLHQW JURXS PD\ EH EHQHILFLDO $V SDUW RI WKH39 
intervention, nurse specialists could be trained to assess current sexuality needs, but also provide 40 
education for anticipated, adjustment issues that involve sexuality, body image and intimacy, and 41 
UHODWLRQVKLSVZLWKRQH·VSDUWQHURUWKHDEVHQFHRIDURPDQWLFUHODWLRQVKLS(Kotronoulas et al., 2009).  42 
 43 
Strengths and limitations 44 
In this study, we adopted a phased approach, whereby we thoroughly reviewed the existent literature 45 
and subsequently engaged patients and health professionals as research collaborators. This technique 46 
helped us to customise and refine aspects of the intervention in an attePSWWRPHHWXVHUV·SUHIHUHQFHV47 
H[SHFWDWLRQVDQGSULRULWLHV DQG LQFUHDVH WKH LQWHUYHQWLRQ·V IHDVLELOLW\ DQGDFFHSWDELOLW\6HFRQGZH48 
relied on a widely used and well-validated PROM to collect information in a reliable and comprehensive 49 
way. Third, we empOR\HGGLIIHUHQWVRXUFHVRILQIRUPDWLRQWRFRPSUHKHQVLYHO\LQYHVWLJDWHWKHVWXG\·V50 
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feasibility and acceptability, including observation, questionnaire and interview data. Last, evaluation of 1 
the intervention with minimal research support and in clinical practice assimilation conditions increases 2 
our confidence that implementation of such an intervention can be a realistic and achievable goal within 3 
NHS. 4 
The study should nonetheless be interpreted in the context of a number of key limitations. 5 
Consultation appointments were not timed; therefore, we cannot reliably report the overall and 6 
average time commitment for patients and CNS. Nevertheless, none of the participants reported the 7 
intervention as time-FRQVXPLQJ7RDVVHVVSDWLHQWV·FRJQLWLYHQHHGVZHGHYHORped and used an item 8 
based on existing questionnaires. Although face validity of this new item was established, its 9 
content/construct validity remains unknown. To make use of all available data, we relied on missing 10 
values replacement via multiple imputation. Multiple imputation is the method of choice in dealing with 11 
missing data, yet the possibility of under- or over-estimation cannot be entirely ruled out. With a 12 
smaller than planned sample size, the accuracy of feasibility and/or effect size estimates might have 13 
been compromised. This small sample size has also prevented us from testing the influence of 14 
demographic/clinical characteristics as moderators of feasibility and unmet needs. Only 3 out of 12 15 
consenting patients participated in end-of-study interviews. Although participation was more 16 
influenced by patients not being contactable rather than expressly refusing attendance, one might 17 
consider the available interview data as skewed towards more positive views and opinions. However, 18 
this effect is likely to only be minimal given the high retention and data completeness rates. Finally, this 19 
was a single-centre study, thus reflecting current facilitators and barriers in the implementation of 20 
PROMs-driven supportive care intervention for people with CRC within one NHS board only. 21 
Whether the feasibility and/or acceptability of this intervention are similar in diverse clinical contexts 22 
requires further investigation. 23 
 24 
Implications for clinical practice and research 25 
PROM data should be regularly audited and assist in the provision of supportive care to people with 26 
CRC and should be able to be accessed by all members of the multidisciplinary team. A standardised 27 
needs assessment PROM could be implemented within clinical practice at the beginning and the end 28 
of treatment, and during long-term follow-up, both for adjuvant and metastatic patients with CRC. In 29 
the interest of implementation of this intervention, a concise, yet comprehensive and informative, 30 
clinical tool may be more appropriate in busy clinical settings. Special attention should be given to 31 
salient patient needs that may be heightened during transition to the post-chemotherapy period. Such 32 
QHHGV LQFOXGH GHDOLQJ ZLWK FKDQJHV WR RQH·V URXWLQH OLIHVW\OH DQG VH[XDO UHODWLRQVKLSV ILJKWLQJ33 
depression, geWWLQJFRQWURORIRQH·VVLWXDWLRQPDLQWDLQLQJ LQGHSHQGHQFHRU IHHOLQJXVHIXOWRRWKHUV34 
and the society. Colorectal CNS (particularly those junior ones) may benefit from formal education 35 
with regard to pervasive concerns of this patient group (e.g. psychosocial adjustment and difficulty to 36 
return to normal) and associated management strategies. Employing phone or Skype calls to deliver 37 
consultations may facilitate patient attendance for those patients physically or otherwise unable or 38 
limited to visit the hospital, and reduce workload associated with face-to-face consultations for CNS. 39 
A pilot randomised controlled trial is warranted to provide preliminary evidence on the effectiveness 40 
and cost-effectiveness of this PROMs-driven, nurse-led supportive care needs intervention. The 41 
feasibility and acceptability of the use of electronic needs assessment PROMs (e.g. available via the 42 
Internet or on tablet PCs) should be explored as an alternative means of administration and data 43 
collection. The feasibility and acceptability of the use of automated reports/summaries/graphs of 44 
expressed needs based on the use of electronic platforms to administer PROMs should be explored 45 
as a less time-consuming means of data interpretation and communication between patients and health 46 
professionals. Finally, the impact of PROMs-driven supportive care on important patient outcomes 47 
(e.g. quality of life, self-efficacy, psychosocial adjustment, work presenteeism, and/or routine non-48 
work-related activities, survival) and health service utilisation outcomes (e.g. emergency presentation, 49 
hospital re-admissions) should be established. 50 
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 1 
Conclusions 2 
The use of PROMs by CNS in the delivery of supportive care to people with CRC appears to be 3 
feasible and acceptable. Congruent with the literature, this study illustrates that CNS are key 4 
professionals in the delivery of supportive care, and able to act upon information gleaned from needs 5 
assessment PROMs used in clinical practice. Whilst the findings do provide some evidence to support 6 
the future use of PROMs in this area, the results of this study are still tentative and warrant 7 
confirmation in a larger randomised controlled trial in order to demonstrate the positive impact of 8 
the delivery of PROMs-driven supportive care on patient outcomes. 9 
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Figure captions 
 
Figure 1. Individual trajectories in numbers of unmet needs. 
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Tables 
 
Table 1. Descriptive statistics 
Variable   
Age (years) Mean (SD) 64.1(8.2)  
Median 65.5 
Range 51-75 
 n (%) 
Age (years) 50-59 5 (35.7) 
60-69 4 (28.6) 
70+ 5 (35.7) 
Gender Male 9 (64.3) 
Female 5 (35.7) 
Educational attainment High School 12 (85.8) 
Some college 1 (7.1) 
University 1 (7.1) 
Employment Employed 5 (35.7) 
Unemployed 2 (14.3) 
Retired 7 (50.0) 
Marital status Married/partnered 12 (85.8) 
Widowed 2 (14.3) 
Cancer type Colon 12 (85.8) 
Rectum 2 (14.3) 
Cancer staging I 2 (14.3) 
II (A or B) 2 (14.3) 
III (A, B, or C) 8 (57.1) 
IV 2 (14.3) 
Surgery Yes 9 (64.3) 
Chemotherapy Yes 14 (100.0) 
Radiotherapy Yes 4 (28.6) 
Supportive care Yes 0 (0.0) 
Any comorbidities Yes 0 (0.0) 
ECOG PS 0 (fully active) 6 (42.9) 
1 (restricted in strenuous 
physical activity) 
8 (57.1) 
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Table 2. Over-time changes in the ranking of the most prevalent unmet needs 
identified at baseline (T1). 
Item 
T1 T2 T3 
rank rank rank 
Fears about the cancer spreading 1 2 3 
Fears about the cancer returning 1 1 1 
Lack of energy and tiredness 2 3 2 
Not being able to do the things you used to do 2 3 2 
Uncertainty about the future 2 6 5 
Concerns about the worries of those close to you 2 4 3 
Changes to your usual routine and lifestyle 3 4 1 
Worry that the results of treatment are beyond 
your control 
4 7 3 
Concerns about the ability of those close to you 
to cope with caring for you 
4 6 5 
Concerns about your financial situation 4 8 6 
Feeling bored and/or useless 5 5 2 
Anxiety 5 8 5 
Feeling down or depressed 5 5 3 
Keeping a positive outlook 5 5 5 
Feelings about death and dying 5 9 6 
 
 
Table 3. Descriptive statistics of SCNS-LF59 domain scores (unstandardised and standardised scores) 
Domains 
Unstandardised scores Standardised scores* 
T1 T2 T3 T1 T2 T3 
Physical/daily living       
Mean (SD) 15.1 (5.7) 14.5 (5.4) 13.3 (5.2) 29.1 (20.2) 26.8 (19.4) 22.4 (18.6) 
Median 15.5 14.5 12.5 30.4 26.8 19.7 
Range 7-24 7-22 7-25 0-60.7 0-53.6 0-64.3 
Psychological 
      
Mean (SD) 50.0 (17.7) 48.9 (15.8) 44.9 (18.3) 31.8 (20.1) 30.6 (18.0) 26.1 (20.8) 
Median 51.0 51.5 35.0 33.0 33.5 14.8 
Range 23-77 25-70 25-82 1.1-62.5 3.4-54.5 3.4-68.2 
Sexuality 
      
Mean (SD) 6.0 (1.8) 5.1 (2.6) 6.2 (2.3) 25.0 (15.3) 17.3 (21.8) 26.8 (19.4) 
Median 6.0 5.0 6.0 25.0 16.7 25.0 
Range 3-9 3-13 3-11 0-50.0 0-83.3 0-66.7 
Health system and 
information 
      
Mean (SD) 26.9 (7.1) 26.2 (6.6) 26.1 (6.0) 19.9 (11.8) 18.7 (10.9) 18.5 (9.9) 
Median 29.0 28.0 28.0 23.3 21.7 21.7 
Range 15-37 15-33 15-36 0-36.7 0-30.0 0-35.0 
Patient care and 
support 
      
Mean (SD) 13.1 (4.3) 12.1 (3.1) 12.9 (3.6) 15.9 (13.3) 12.7 (9.8) 15.2 (11.2) 
Median 13.5 12.0 13.5 17.2 12.5 17.2 
Range 8-21 8-16 8-17 0-40.6 0-25.0 0-28.1 
*Standardised scores are based on unstandardised (original) domain scores, using the following formula: (x-m)*[100/(m(k-
1))], where x=unstandardised domain score; m=number of items on domain; k=value of the maximum response for each 
item. Unstandardised scores have possible values ranging as follows: physical/daily living=7-35, psychological=22-110, 
sexuality=3-15, health system and information=15-75; patient care and support=8-40. Standardised scores have possible 
values ranging from 0 to 100. 
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Table 4. Effect sizes of over-time changes in domain scores. 
 ES.T1-T2 ES.T2-T3 ES.T1-T3 
Physical/daily living -0.11 -0.22 -0.33 
Psychological -0.06 -0.25 -0.29 
Sexuality -0.51 0.44 0.11 
Health system and information -0.10 -0.02 -0.12 
Patient care and support -0.23 0.25 -0.05 
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